Delphi
Delphi supports research and development teams building modular wearable and ingestible biosensors to continuously monitor internal biological signals, detect disease earlier, and guide treatment.
This grant was recently updated
ARPA-H replaced Delphi’s solicitation section with selected awardees, removing the April 8, 2026 solution-summary and May 13, 2026 full-proposal deadlines and application links. The FAQ page is no longer available, and Leonard Tender replaces Paul E. Sheehan as program manager.
Funder: Advanced Research Projects Agency for Health
Due Dates: No application deadline listed
Funding Amounts: Not specified
Summary: Delphi supports modular wearable and ingestible biosensors for continuous monitoring of deep biological signals, earlier disease detection, and treatment guidance.
Description
Delphi is an Advanced Research Projects Agency for Health (ARPA-H) program developing a reusable ecosystem for bioelectronics and sensing technologies. It aims to replace bulky, expensive, single-purpose biosensors with tiny, smart “chiplets” that can be mixed and matched across wearable and ingestible devices. These building blocks are intended to provide continuous, real-time insights into internal signals such as hormones, immune markers, and therapeutic drug levels.
The program combines chiplet microelectronics, ultra-low-power management, secure communications, and advanced bio-interfaces. It brings together microelectronics, materials science, bioanalytical chemistry, and cybersecurity expertise to build open, reusable architectures and standards. Its goals include more accurate, affordable, and reliable monitoring, enabling clinicians to detect early signs of disease and remotely adjust treatments while helping people better understand and manage their health.
